1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

18 Dec 2020
Admin
News Article

Genscript And Innobation Enter Into The Agreement For Car-T Therapy

A Global Leading Biotech Company Genscript Biotech Corporation Announces That It Has Reached The Agreement For Cell Line Development And Engineering, Manufacture Service Of Gmp Plasmids And Lentivirus With Innobation Co., Ltd. A Company That Specializes In Developing Biomarkers And Car-T Cell Treatment Products.Innobation Is A Republic Of Korea Based Biotech Company, Currently Working Closely With The Korean National Cancer Center On The 'Ibc 101' Project, A Bi-Specific Car-T Therapy Product, And Several Other Car-T Projects For Hematological Malignancies And Solid Tumors.Through This Agreement, Genscript Will Provide Cro Services For Developing Engineered Cell Line Using Crispr Cas 9 Technology And Genscript Probio, The Cdmo Division Of Genscript, Will Offer High-Quality One-Stop Platform Services Of Developing And Manufacturing Plasmid And Lentivirus For Preclinical And Clinical Trials, Which Would Be Required For Innobation'S Car-T Therapy Development."We Are Delighted To Reach Collaboration With Innobation In The Field Of Car-T Therapy. In Recent Years, The Republic Of Korea Has Sprouted Many Innovative Biotech Companies, And Innobation Is One Of Leading Innovative Technology Companies With The Latest Technology For Immunotherapy." Yuyu Hu, Business Development Head Of Genscript Korea Said, "We Look Forward To Applying Our Superior Process Development Capabilities Together With Innobation'S Insight Into Immunotherapeutic Drug Discovery And Development To Truly Forge New Frontiers In Bringing Personalized Immunotherapies To Patients.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!